BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 23477159)

  • 1. [Reevaluation on adverse reaction monitoring and safety of proprietary Chinese medicines of Chongqing from 2005 to 2011].
    Yang YY; Dong Z; Zhu SB; Sun HF; Yang MP
    Zhongguo Zhong Yao Za Zhi; 2012 Dec; 37(23):3659-63. PubMed ID: 23477159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preliminary study on general safe medication regularity of Chinese patent orthopedic medicines based on adverse reaction/event literature analysis].
    Wang YG; Shi XY; Jin R; Li HY; Kong XW; Qiao YJ
    Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(6):1192-7. PubMed ID: 26226769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of 103 cases with adverse drug reactions induced by sanqizongzaogan injection].
    Chen Y; Li Y; Zhu G
    Zhongguo Zhong Yao Za Zhi; 2010 Jan; 35(2):237-9. PubMed ID: 20394303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chinese medicine adverse reactions' literature statistical analysis in recent five years].
    Xiang F; Zhang X
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(19):2755-8. PubMed ID: 22242443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacovigilance practice and risk control of Traditional Chinese Medicine drugs in China: current status and future perspective.
    Zhang L; Yan J; Liu X; Ye Z; Yang X; Meyboom R; Chan K; Shaw D; Duez P
    J Ethnopharmacol; 2012 Apr; 140(3):519-25. PubMed ID: 22374080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis and countermeasures of adverse drug reactions of traditional Chinese medicine injections in children].
    Zhang XL; Li M; Rong P; Ma R
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2807-9. PubMed ID: 23285940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of adverse reactions and pharmacovigilance research to parenterally administered shuxuening].
    Yang W; Xiang YY; Xie YM; Shen H
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3013-8. PubMed ID: 24471322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosteroid adulteration in proprietary Chinese medicines: a recurring problem.
    Chong YK; Ching CK; Ng SW; Mak TW
    Hong Kong Med J; 2015 Oct; 21(5):411-6. PubMed ID: 26314568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interpretation of adverse drug reaction reporting and monitoring and significance of traditional Chinese medicine adverse drug reaction monitoring].
    Wang D; Du XX
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2686-8. PubMed ID: 23285908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of analysis 1 390 adverse drug reactions cases of parenterally administered dengzhan xixin based on China's spontaneous response system].
    Li YY; Xiang YY; Xie YM; Shen H
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):2998-3002. PubMed ID: 24471319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Enlightenment of adverse reaction monitoring on safety evaluation of traditional Chinese medicines].
    Song HB; Du XX; Ren JT; Yang L; Guo XX; Pang Y
    Zhongguo Zhong Yao Za Zhi; 2015 Apr; 40(8):1620-3. PubMed ID: 26281610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Systematic analysis on clinical safety of Shuxuetong injection].
    Guo XF; Wen ZH; Xie YM; Liu SN; Li ZY; Chen DC
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2782-5. PubMed ID: 23285933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Literature metrology analysis of adverse reactions reports of Denzhanxixin injection].
    Li YY; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2789-91. PubMed ID: 23285935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Spontaneous reportintg system data based on shuxuetong injection adverse reactions signal warning analysis].
    Jiang JJ; Xiang YY; Xie YM; Shen H
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):2994-7. PubMed ID: 24471318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis on 315 cases of clinical adverse drug reaction/event induced by gastrodin].
    Zheng YY; Dong Z; Lu XQ; Xia YP; Zhu SB
    Zhongguo Zhong Yao Za Zhi; 2015 May; 40(10):2037-41. PubMed ID: 26390669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Literature review report on safety evaluation about Kudiezi injection].
    Liao X; Shen H; Xie YM; Zhang W; Yang W; Lv ZG
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2786-8. PubMed ID: 23285934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Discussion on establishment of quality control system for intensive hospital monitoring on traditional Chinese medicine injections].
    Jiang JJ; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2689-91. PubMed ID: 23285909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of post marketing safety reevaluation of shenqi fuzheng injection].
    Ai QH; Li YY; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(18):3633-6. PubMed ID: 25532410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis on reasons for disapproval of registration application of new traditional Chinese medicines in recent years].
    Zhang X; Zhang L; Wang H
    Zhongguo Zhong Yao Za Zhi; 2012 Aug; 37(15):2333-7. PubMed ID: 23193572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Spontaneous reporting system data analysis of parenterally administered Shenmai].
    Wang LX; Xiang YY; Xie YM; Shen H; Ai QH
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):2987-93. PubMed ID: 24471317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.